학술논문
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer
Document Type
Article
Author
Goldberg, K.B.; Pazdur, R.; Beaver, J.A.; Royce, M.; Osgood, C.L.; Amatya, A.K.; Fiero, M.H.; Chang, C.J.G.; Ricks, T.K.; Shetty, K.A.; Kraft, J.; Qiu, J.; Song, P.; Charlab, R.; Yu, J.; King, K.E.; Rastogi, A.; Janelsins, B.; Weinberg, W.C.; Clouse, K.; Borders-Hemphill, V.; Brown, L.; Gomez-Broughton, C.; Li, Z.; Nguyen, T.T.; Qiu, Z.; Ly, A.-T.; Chang, S.; Gao, T.; Tu, C.-M.; King-Kallimanis, B.; Pierce, W.F.; Chiang, K.; Lee, C.; Leighton, J.K.; Tang, S.; Amiri-Kordestani, L.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 15 April 2022, 28(8):1487-1492)
Subject
Language
English
ISSN
15573265
10780432
10780432